Cargando…
Esophageal cancer: Recent advances in screening, targeted therapy, and management
The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor m...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229783/ https://www.ncbi.nlm.nih.gov/pubmed/25395880 http://dx.doi.org/10.4103/1477-3163.143720 |
_version_ | 1782344167820623872 |
---|---|
author | Gaur, Puja Kim, Min P. Dunkin, Brian J. |
author_facet | Gaur, Puja Kim, Min P. Dunkin, Brian J. |
author_sort | Gaur, Puja |
collection | PubMed |
description | The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor marker for surveillance purposes, ways to target esophageal cancer stem cells as well as circulating tumor cells, and developing minimally invasive protocols to treat early-stage disease. The goal of this chapter is to highlight some of the recent advances and ongoing research in the field of esophageal cancer. |
format | Online Article Text |
id | pubmed-4229783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42297832014-11-13 Esophageal cancer: Recent advances in screening, targeted therapy, and management Gaur, Puja Kim, Min P. Dunkin, Brian J. J Carcinog Review Article The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor marker for surveillance purposes, ways to target esophageal cancer stem cells as well as circulating tumor cells, and developing minimally invasive protocols to treat early-stage disease. The goal of this chapter is to highlight some of the recent advances and ongoing research in the field of esophageal cancer. Medknow Publications & Media Pvt Ltd 2014-10-30 /pmc/articles/PMC4229783/ /pubmed/25395880 http://dx.doi.org/10.4103/1477-3163.143720 Text en Copyright: © 2014 Gaur http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Gaur, Puja Kim, Min P. Dunkin, Brian J. Esophageal cancer: Recent advances in screening, targeted therapy, and management |
title | Esophageal cancer: Recent advances in screening, targeted therapy, and
management |
title_full | Esophageal cancer: Recent advances in screening, targeted therapy, and
management |
title_fullStr | Esophageal cancer: Recent advances in screening, targeted therapy, and
management |
title_full_unstemmed | Esophageal cancer: Recent advances in screening, targeted therapy, and
management |
title_short | Esophageal cancer: Recent advances in screening, targeted therapy, and
management |
title_sort | esophageal cancer: recent advances in screening, targeted therapy, and
management |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229783/ https://www.ncbi.nlm.nih.gov/pubmed/25395880 http://dx.doi.org/10.4103/1477-3163.143720 |
work_keys_str_mv | AT gaurpuja esophagealcancerrecentadvancesinscreeningtargetedtherapyandmanagement AT kimminp esophagealcancerrecentadvancesinscreeningtargetedtherapyandmanagement AT dunkinbrianj esophagealcancerrecentadvancesinscreeningtargetedtherapyandmanagement |